JP2016505247A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016505247A5 JP2016505247A5 JP2015544190A JP2015544190A JP2016505247A5 JP 2016505247 A5 JP2016505247 A5 JP 2016505247A5 JP 2015544190 A JP2015544190 A JP 2015544190A JP 2015544190 A JP2015544190 A JP 2015544190A JP 2016505247 A5 JP2016505247 A5 JP 2016505247A5
- Authority
- JP
- Japan
- Prior art keywords
- gene
- tissue sample
- thyroid tissue
- products
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 claims description 106
- 210000001685 thyroid gland Anatomy 0.000 claims description 65
- 239000000523 sample Substances 0.000 claims description 62
- 238000000034 method Methods 0.000 claims description 54
- 230000014509 gene expression Effects 0.000 claims description 52
- 108010031374 Tissue Inhibitor of Metalloproteinase-1 Proteins 0.000 claims description 26
- 101150058049 car gene Proteins 0.000 claims description 26
- 101150037720 CCR7 gene Proteins 0.000 claims description 24
- 101150077124 CXCL10 gene Proteins 0.000 claims description 22
- 239000003153 chemical reaction reagent Substances 0.000 claims description 22
- 101150019010 CCR3 gene Proteins 0.000 claims description 18
- 101150004010 CXCR3 gene Proteins 0.000 claims description 14
- 108091034117 Oligonucleotide Proteins 0.000 claims description 14
- 101000892366 Homo sapiens Actin filament-associated protein 1-like 2 Proteins 0.000 claims description 12
- 101150051753 gene 7 gene Proteins 0.000 claims description 11
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 10
- 208000024770 Thyroid neoplasm Diseases 0.000 claims description 9
- 201000002510 thyroid cancer Diseases 0.000 claims description 9
- 108010018924 Heme Oxygenase-1 Proteins 0.000 claims description 8
- 102100028006 Heme oxygenase 1 Human genes 0.000 claims description 8
- 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 238000002512 chemotherapy Methods 0.000 claims description 4
- 238000001794 hormone therapy Methods 0.000 claims description 4
- 238000001959 radiotherapy Methods 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 102100036301 C-C chemokine receptor type 7 Human genes 0.000 claims description 2
- 101150022250 CXCL11 gene Proteins 0.000 claims description 2
- 101150115558 CXCL9 gene Proteins 0.000 claims description 2
- 101150066398 CXCR4 gene Proteins 0.000 claims description 2
- 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 claims description 2
- 101000582950 Homo sapiens Platelet factor 4 Proteins 0.000 claims description 2
- 101710183399 Keratin, type I cytoskeletal 19 Proteins 0.000 claims description 2
- 108060005251 Nectin Proteins 0.000 claims description 2
- 238000004458 analytical method Methods 0.000 claims description 2
- 239000012472 biological sample Substances 0.000 claims description 2
- 230000002380 cytological effect Effects 0.000 claims description 2
- 230000003247 decreasing effect Effects 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 claims description 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000011273 incision biopsy Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000013188 needle biopsy Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000007388 punch biopsy Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- -1 rRNA Proteins 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261730391P | 2012-11-27 | 2012-11-27 | |
| US61/730,391 | 2012-11-27 | ||
| US201361775419P | 2013-03-08 | 2013-03-08 | |
| US61/775,419 | 2013-03-08 | ||
| PCT/US2013/071970 WO2014085434A1 (en) | 2012-11-27 | 2013-11-26 | Compositions and methods for diagnosing thyroid tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016505247A JP2016505247A (ja) | 2016-02-25 |
| JP2016505247A5 true JP2016505247A5 (enExample) | 2016-12-22 |
| JP6309019B2 JP6309019B2 (ja) | 2018-04-11 |
Family
ID=49880965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015544190A Active JP6309019B2 (ja) | 2012-11-27 | 2013-11-26 | 甲状腺腫瘍を診断するための組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10260103B2 (enExample) |
| EP (1) | EP2925886B1 (enExample) |
| JP (1) | JP6309019B2 (enExample) |
| KR (1) | KR102174578B1 (enExample) |
| CN (1) | CN104937111B (enExample) |
| AU (1) | AU2013352339B2 (enExample) |
| BR (1) | BR112015012239B1 (enExample) |
| CA (1) | CA2892822C (enExample) |
| MX (1) | MX367366B (enExample) |
| NZ (1) | NZ709167A (enExample) |
| WO (1) | WO2014085434A1 (enExample) |
| ZA (1) | ZA201504663B (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8338109B2 (en) | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| CA2725978A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
| EP3360978A3 (en) | 2009-05-07 | 2018-09-26 | Veracyte, Inc. | Methods for diagnosis of thyroid conditions |
| US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| EP2791359B1 (en) | 2011-12-13 | 2020-01-15 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| ES3015226T3 (en) | 2012-08-16 | 2025-04-30 | Veracyte Sd Inc | Prostate cancer prognosis using biomarkers |
| CN104937111B (zh) | 2012-11-27 | 2018-05-11 | 智利天主教教皇大学 | 用于诊断甲状腺肿瘤的组合物和方法 |
| EP2968988A4 (en) | 2013-03-14 | 2016-11-16 | Allegro Diagnostics Corp | METHOD FOR EVALUATING A COPD STATUS |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| CN114606309A (zh) | 2014-11-05 | 2022-06-10 | 威拉赛特公司 | 使用机器学习和高维转录数据的诊断系统和方法 |
| JP6144314B2 (ja) * | 2015-10-30 | 2017-06-07 | 株式会社Ｕｂｉｃ | データ分類システム，方法，プログラムおよびその記録媒体 |
| WO2017117523A1 (en) * | 2015-12-31 | 2017-07-06 | Quest Diagnostics Investments Llc | Compositions and methods for screening mutations in thyroid cancer |
| US11486873B2 (en) | 2016-03-31 | 2022-11-01 | Ontera Inc. | Multipore determination of fractional abundance of polynucleotide sequences in a sample |
| EP3504348B1 (en) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| SG11201901866TA (en) | 2016-09-02 | 2019-03-28 | Univ Texas | Collection probe and methods for the use thereof |
| EP3800469A1 (en) * | 2016-10-24 | 2021-04-07 | Ontera Inc. | Fractional abundance of polynucleotide sequences in a sample |
| WO2018132916A1 (en) | 2017-01-20 | 2018-07-26 | Genomedx Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| AU2018230784A1 (en) | 2017-03-09 | 2019-10-10 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| WO2018205035A1 (en) | 2017-05-12 | 2018-11-15 | Genomedx Biosciences, Inc | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| WO2019028285A2 (en) | 2017-08-04 | 2019-02-07 | Genomedx, Inc. | USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY |
| KR20250047324A (ko) | 2017-08-07 | 2025-04-03 | 더 존스 홉킨스 유니버시티 | 암을 평가하고 치료하기 위한 방법 및 재료 |
| BR112020010416A2 (pt) | 2017-11-27 | 2020-12-15 | Board Of Regents, The University Of Texas System | Sonda de coleta minimamente invasiva e métodos para o seu uso |
| WO2019165351A1 (en) * | 2018-02-23 | 2019-08-29 | Board Of Regents, The University Of Texas System | Tissue analysis by mass spectrometry |
| CN109457032B (zh) * | 2018-12-20 | 2022-04-12 | 北京优迅医学检验实验室有限公司 | 甲状腺癌分子诊断试剂盒 |
| EP3914891B1 (en) | 2019-01-25 | 2026-04-01 | Board of Regents, The University of Texas System | Apparatus for cleaning and/or exchanging medical devices |
| CN109847072A (zh) * | 2019-02-27 | 2019-06-07 | 四川大学华西医院 | 一种甲状旁腺血供检测试剂盒 |
| RU2712080C1 (ru) * | 2019-05-14 | 2020-01-24 | Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) | Способ проведения цитологического исследования при дифференциальной диагностике узловых образований щитовидной железы |
| EP4425506A3 (en) * | 2019-05-22 | 2024-12-04 | Grail, Inc. | Systems and methods for determining whether a subject has a cancer condition using transfer learning |
| WO2021138661A1 (en) * | 2020-01-03 | 2021-07-08 | The University Of Toledo | Stratifying risk of malignancy in indeterminate thyroid nodules and immuno-genomic markers for early detection of thyroid cancer |
| KR102639140B1 (ko) * | 2020-08-14 | 2024-02-20 | 연세대학교 산학협력단 | 조직 검사 방법 및 조직 검사 장치 |
| US20240052422A1 (en) | 2020-12-24 | 2024-02-15 | Pontificia Universidad Catolica De Chile | In-vitro method for diagnosing and predicting the aggressiveness of thyroid cancer, and the precision surgery options and type to be used to remove a tumour from a patient; kit; reagents forming the kit; and use of the reagents and use of molecular markers as part of the method |
| EP4023770A1 (en) | 2021-01-05 | 2022-07-06 | Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Oddzial w Gliwicach | A method of examining genes for the diagnosis of thyroid tumors, a set for the diagnosis of thyroid tumors and application |
| US12245355B2 (en) | 2021-02-19 | 2025-03-04 | Mevion Medical Systems, Inc. | Gantry for a particle therapy system |
| EP4317458A4 (en) * | 2021-03-30 | 2025-03-05 | Nippon Medical School Foundation | FOLLICULAR THYROID CANCER-SPECIFIC MARKER |
| CN115807081B (zh) * | 2021-09-15 | 2026-06-12 | 江苏鹍远生物技术有限公司 | 诊断甲状腺癌的基因标志物及其用途 |
| EP4303323B1 (en) | 2022-07-05 | 2025-02-19 | Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Oddzial w Gliwicach | A method differentiating benign and malignant tyroid nodules |
| EP4303324A1 (en) | 2022-07-05 | 2024-01-10 | Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Oddzial w Gliwicach | A method of distinguishing between benign and malignant thyroid nodules |
Family Cites Families (122)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US5766960A (en) | 1987-07-27 | 1998-06-16 | Australian Membrane And Biotechnology Research Institute | Receptor membranes |
| US5130238A (en) | 1988-06-24 | 1992-07-14 | Cangene Corporation | Enhanced nucleic acid amplification process |
| GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
| US5856092A (en) | 1989-02-13 | 1999-01-05 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
| US5547839A (en) | 1989-06-07 | 1996-08-20 | Affymax Technologies N.V. | Sequencing of surface immobilized polymers utilizing microflourescence detection |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6309822B1 (en) | 1989-06-07 | 2001-10-30 | Affymetrix, Inc. | Method for comparing copy number of nucleic acid sequences |
| US5925525A (en) | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5871928A (en) | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| WO1991001384A1 (en) | 1989-07-11 | 1991-02-07 | Gen-Probe, Incorporated | Nucleic acid sequence amplification methods utilizing a transcription complex |
| CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
| US5455166A (en) | 1991-01-31 | 1995-10-03 | Becton, Dickinson And Company | Strand displacement amplification |
| US5936731A (en) | 1991-02-22 | 1999-08-10 | Applied Spectral Imaging Ltd. | Method for simultaneous detection of multiple fluorophores for in situ hybridization and chromosome painting |
| US5270184A (en) | 1991-11-19 | 1993-12-14 | Becton, Dickinson And Company | Nucleic acid target generation |
| US5412087A (en) | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
| US5541061A (en) | 1992-04-29 | 1996-07-30 | Affymax Technologies N.V. | Methods for screening factorial chemical libraries |
| JP3954092B2 (ja) | 1993-06-25 | 2007-08-08 | アフィメトリックス インコーポレイテッド | 核酸配列のハイブリダイゼーションと配列決定 |
| US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| US6045996A (en) | 1993-10-26 | 2000-04-04 | Affymetrix, Inc. | Hybridization assays on oligonucleotide arrays |
| US6090555A (en) | 1997-12-11 | 2000-07-18 | Affymetrix, Inc. | Scanned image alignment systems and methods |
| CA2185239C (en) | 1994-03-16 | 2002-12-17 | Nanibhushan Dattagupta | Isothermal strand displacement nucleic acid amplification |
| US5648211A (en) | 1994-04-18 | 1997-07-15 | Becton, Dickinson And Company | Strand displacement amplification using thermophilic enzymes |
| US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
| US6287850B1 (en) | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
| US6379897B1 (en) | 2000-11-09 | 2002-04-30 | Nanogen, Inc. | Methods for gene expression monitoring on electronic microarrays |
| US5795716A (en) | 1994-10-21 | 1998-08-18 | Chee; Mark S. | Computer-aided visualization and analysis system for sequence evaluation |
| US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
| US5733729A (en) | 1995-09-14 | 1998-03-31 | Affymetrix, Inc. | Computer-aided probability base calling for arrays of nucleic acid probes on chips |
| US5843655A (en) | 1995-09-18 | 1998-12-01 | Affymetrix, Inc. | Methods for testing oligonucleotide arrays |
| US6300063B1 (en) | 1995-11-29 | 2001-10-09 | Affymetrix, Inc. | Polymorphism detection |
| EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
| US5837196A (en) | 1996-01-26 | 1998-11-17 | The Regents Of The University Of California | High density array fabrication and readout method for a fiber optic biosensor |
| WO1997029212A1 (en) | 1996-02-08 | 1997-08-14 | Affymetrix, Inc. | Chip-based speciation and phenotypic characterization of microorganisms |
| US6114122A (en) | 1996-03-26 | 2000-09-05 | Affymetrix, Inc. | Fluidics station with a mounting system and method of using |
| US6238866B1 (en) | 1996-04-16 | 2001-05-29 | The United States Of America As Represented By The Secretary Of The Army | Detector for nucleic acid typing and methods of using the same |
| GB9609262D0 (en) | 1996-05-02 | 1996-07-03 | Isis Innovation | Peptide library and method |
| US5958342A (en) | 1996-05-17 | 1999-09-28 | Incyte Pharmaceuticals, Inc. | Jet droplet device |
| US5853993A (en) | 1996-10-21 | 1998-12-29 | Hewlett-Packard Company | Signal enhancement method and kit |
| CA2702219C (en) | 1996-11-06 | 2013-01-08 | Sequenom, Inc. | High density immobilization of nucleic acids |
| US5804386A (en) | 1997-01-15 | 1998-09-08 | Incyte Pharmaceuticals, Inc. | Sets of labeled energy transfer fluorescent primers and their use in multi component analysis |
| US6309824B1 (en) | 1997-01-16 | 2001-10-30 | Hyseq, Inc. | Methods for analyzing a target nucleic acid using immobilized heterogeneous mixtures of oligonucleotide probes |
| US6368799B1 (en) | 1997-06-13 | 2002-04-09 | Affymetrix, Inc. | Method to detect gene polymorphisms and monitor allelic expression employing a probe array |
| US6333179B1 (en) | 1997-06-20 | 2001-12-25 | Affymetrix, Inc. | Methods and compositions for multiplex amplification of nucleic acids |
| US6420108B2 (en) | 1998-02-09 | 2002-07-16 | Affymetrix, Inc. | Computer-aided display for comparative gene expression |
| US6484183B1 (en) | 1997-07-25 | 2002-11-19 | Affymetrix, Inc. | Method and system for providing a polymorphism database |
| ATE280246T1 (de) | 1997-08-15 | 2004-11-15 | Affymetrix Inc | Polymorphismuserkennung mit hilfe cluster-analyse |
| US6511803B1 (en) | 1997-10-10 | 2003-01-28 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
| JP2001521753A (ja) | 1997-10-31 | 2001-11-13 | アフィメトリックス インコーポレイテッド | 成人臓器及び胎児臓器中の発現プロフィール |
| US6054274A (en) | 1997-11-12 | 2000-04-25 | Hewlett-Packard Company | Method of amplifying the signal of target nucleic acid sequence analyte |
| US6013449A (en) | 1997-11-26 | 2000-01-11 | The United States Of America As Represented By The Department Of Health And Human Services | Probe-based analysis of heterozygous mutations using two-color labelling |
| CA2319828A1 (en) | 1998-01-29 | 1999-08-05 | Miller, Samuel | High density arrays for proteome analysis and methods and compositions therefor |
| US6280954B1 (en) | 1998-02-02 | 2001-08-28 | Amersham Pharmacia Biotech Ab | Arrayed primer extension technique for nucleic acid analysis |
| US6083726A (en) | 1998-02-03 | 2000-07-04 | Lucent Technologies, Inc. | Methods for polynucleotide synthesis and articles for polynucleotide hybridization |
| ATE393912T1 (de) | 1998-02-04 | 2008-05-15 | Invitrogen Corp | Microarrays und ihre verwendungen |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US6004755A (en) | 1998-04-07 | 1999-12-21 | Incyte Pharmaceuticals, Inc. | Quantitative microarray hybridizaton assays |
| US6284497B1 (en) | 1998-04-09 | 2001-09-04 | Trustees Of Boston University | Nucleic acid arrays and methods of synthesis |
| US6525185B1 (en) | 1998-05-07 | 2003-02-25 | Affymetrix, Inc. | Polymorphisms associated with hypertension |
| US6268210B1 (en) | 1998-05-27 | 2001-07-31 | Hyseq, Inc. | Sandwich arrays of biological compounds |
| US6306643B1 (en) | 1998-08-24 | 2001-10-23 | Affymetrix, Inc. | Methods of using an array of pooled probes in genetic analysis |
| US6185561B1 (en) | 1998-09-17 | 2001-02-06 | Affymetrix, Inc. | Method and apparatus for providing and expression data mining database |
| US6203989B1 (en) | 1998-09-30 | 2001-03-20 | Affymetrix, Inc. | Methods and compositions for amplifying detectable signals in specific binding assays |
| US6316193B1 (en) | 1998-10-06 | 2001-11-13 | Origene Technologies, Inc. | Rapid-screen cDNA library panels |
| US6262216B1 (en) | 1998-10-13 | 2001-07-17 | Affymetrix, Inc. | Functionalized silicon compounds and methods for their synthesis and use |
| DE69929542T2 (de) | 1998-10-27 | 2006-09-14 | Affymetrix, Inc., Santa Clara | Komplexitätsmanagement und analyse genomischer dna |
| US6263287B1 (en) | 1998-11-12 | 2001-07-17 | Scios Inc. | Systems for the analysis of gene expression data |
| US6309828B1 (en) | 1998-11-18 | 2001-10-30 | Agilent Technologies, Inc. | Method and apparatus for fabricating replicate arrays of nucleic acid molecules |
| US6245518B1 (en) | 1998-12-11 | 2001-06-12 | Hyseq, Inc. | Polynucleotide arrays and methods of making and using the same |
| US6351712B1 (en) | 1998-12-28 | 2002-02-26 | Rosetta Inpharmatics, Inc. | Statistical combining of cell expression profiles |
| WO2000042222A2 (en) | 1999-01-15 | 2000-07-20 | Gene Logic Inc. | Immobilized nucleic acid hybridization reagent and method |
| US6251601B1 (en) | 1999-02-02 | 2001-06-26 | Vysis, Inc. | Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays |
| US6329145B1 (en) | 1999-02-09 | 2001-12-11 | Gilead Science, Inc. | Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligand |
| US6177248B1 (en) | 1999-02-24 | 2001-01-23 | Affymetrix, Inc. | Downstream genes of tumor suppressor WT1 |
| EP1159615A2 (en) | 1999-03-10 | 2001-12-05 | National Institutes of Health, as represented by the Secretary, Department of Health and Human Services of the Government | Universal protein array system |
| WO2000061806A2 (en) | 1999-04-09 | 2000-10-19 | Arcturus Engineering, Inc. | GENERIC cDNA OR PROTEIN ARRAY FOR CUSTOMIZED ASSAYS |
| US6284465B1 (en) | 1999-04-15 | 2001-09-04 | Agilent Technologies, Inc. | Apparatus, systems and method for locating nucleic acids bound to surfaces |
| US6268141B1 (en) | 1999-05-12 | 2001-07-31 | Beckman Coulter, Inc. | Immobilization of unmodified biopolymers to acyl fluoride activated substrates |
| ATE318932T1 (de) | 1999-08-13 | 2006-03-15 | Univ Yale | Binär kodierte sequenzmarker |
| US6171797B1 (en) | 1999-10-20 | 2001-01-09 | Agilent Technologies Inc. | Methods of making polymeric arrays |
| US6372431B1 (en) | 1999-11-19 | 2002-04-16 | Incyte Genomics, Inc. | Mammalian toxicological response markers |
| DE19957827C2 (de) | 1999-11-25 | 2003-06-12 | Epigenomics Ag | Verwendung eines Oligomer-Arrays mit PNA- und/oder DNA-Oligomeren auf einer Oberfläche |
| US6383749B2 (en) | 1999-12-02 | 2002-05-07 | Clontech Laboratories, Inc. | Methods of labeling nucleic acids for use in array based hybridization assays |
| WO2001057259A1 (en) | 2000-02-03 | 2001-08-09 | Research Development Foundation | Signaling aptamers that transduce molecular recognition to a differential signal |
| US6267152B1 (en) | 2000-02-18 | 2001-07-31 | Wisconsin Label Corporation | Hang tag and method of applying hang tag to an elongated object |
| US6376191B1 (en) | 2000-03-22 | 2002-04-23 | Mergen, Ltd. | Microarray-based analysis of polynucleotide sequence variations |
| AU2001259631A1 (en) | 2000-05-16 | 2001-11-26 | Genway Biotech, Inc. | Methods and vectors for generating antibodies in avian species and uses therefor |
| PT1297338E (pt) | 2000-06-05 | 2007-05-31 | Novartis Vaccines & Diagnostic | Microarrays para efectuar análises proteómicas |
| US6531283B1 (en) | 2000-06-20 | 2003-03-11 | Molecular Staging, Inc. | Protein expression profiling |
| US6386749B1 (en) | 2000-06-26 | 2002-05-14 | Affymetrix, Inc. | Systems and methods for heating and mixing fluids |
| US6380377B1 (en) | 2000-07-14 | 2002-04-30 | Applied Gene Technologies, Inc. | Nucleic acid hairpin probes and uses thereof |
| WO2002031463A2 (en) | 2000-08-31 | 2002-04-18 | Motorola, Inc. | High density column and row addressable electrode arrays |
| JP2002071687A (ja) | 2000-08-31 | 2002-03-12 | Canon Inc | 変異遺伝子のスクリーニング方法 |
| AU2001292959A1 (en) | 2000-09-22 | 2002-04-02 | Clontech Laboratories, Inc. | Highly sensitive proteomic analysis methods and kits and systems for practicing the same |
| US6632611B2 (en) | 2001-07-20 | 2003-10-14 | Affymetrix, Inc. | Method of target enrichment and amplification |
| US6872529B2 (en) | 2001-07-25 | 2005-03-29 | Affymetrix, Inc. | Complexity management of genomic DNA |
| US7011945B2 (en) | 2001-12-21 | 2006-03-14 | Eastman Kodak Company | Random array of micro-spheres for the analysis of nucleic acids |
| US7011949B2 (en) | 2002-09-30 | 2006-03-14 | Agilent Technologies, Inc. | Methods and compositions for producing labeled probe nucleic acids for use in array based comparative genomic hybridization applications |
| US7028629B2 (en) | 2003-02-03 | 2006-04-18 | Richard Walcome | Self-sealing port light assembly |
| US20070037186A1 (en) | 2005-05-20 | 2007-02-15 | Yuqiu Jiang | Thyroid fine needle aspiration molecular assay |
| US7598052B2 (en) | 2005-10-11 | 2009-10-06 | The Regents Of The University Of Michigan | Expression profile of thyroid cancer |
| EP1777523A1 (en) * | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| US20080090242A1 (en) * | 2006-09-29 | 2008-04-17 | Schering Corporation | Panel of biomarkers for prediction of fti efficacy |
| WO2009111881A1 (en) | 2008-03-13 | 2009-09-17 | British Columbia Cancer Agency Branch | Biomarkers for diagnosis of differentiated thyroid cancer |
| CN101608227A (zh) * | 2008-06-20 | 2009-12-23 | 上海主健生物工程有限公司 | 甲状腺癌遗传检测试剂盒 |
| JP2010022236A (ja) | 2008-07-16 | 2010-02-04 | Fujifilm Corp | 甲状腺癌の検出方法 |
| CA2733910A1 (en) * | 2008-08-12 | 2010-02-18 | Decode Genetics Ehf. | Genetic variants useful for risk assessment of thyroid cancer |
| EP3831954A3 (en) | 2008-11-17 | 2021-10-13 | Veracyte, Inc. | Methods and compositions of molecular profiling for disease diagnostics |
| US9206482B2 (en) * | 2009-04-29 | 2015-12-08 | Genomedx Biosciences Inc. | Systems and methods for expression-based classification of thyroid tissue |
| EP3360978A3 (en) * | 2009-05-07 | 2018-09-26 | Veracyte, Inc. | Methods for diagnosis of thyroid conditions |
| US20120252022A1 (en) | 2009-09-21 | 2012-10-04 | Paul Walfish | Methods and compositions for the diagnosis and treatment of thyroid cancer |
| EP2366800A1 (en) | 2010-03-01 | 2011-09-21 | Centrum Onkologii-Instytut im M. Sklodowskiej-Curie Oddzial w Gliwicach | Kit, method and use for the diagnosis of papillary thyroid cancer using a gene expression profile |
| MD4038C1 (ro) | 2010-03-03 | 2011-01-31 | Univ Nicolae Testemitanu | Procedeu de prognozare a riscului de dezvoltare a cancerului glandei tiroide |
| WO2011137519A1 (en) | 2010-05-07 | 2011-11-10 | Paul Walfish | Methods and compositions for the diagnosis and treatment of thyroid cancer |
| US20110312520A1 (en) | 2010-05-11 | 2011-12-22 | Veracyte, Inc. | Methods and compositions for diagnosing conditions |
| CN103468789A (zh) * | 2012-06-09 | 2013-12-25 | 解码（上海）生物医药科技有限公司 | 甲状腺癌易感基因无创检测试剂盒 |
| CN104937111B (zh) | 2012-11-27 | 2018-05-11 | 智利天主教教皇大学 | 用于诊断甲状腺肿瘤的组合物和方法 |
-
2013
- 2013-11-26 CN CN201380071054.0A patent/CN104937111B/zh active Active
- 2013-11-26 KR KR1020157017018A patent/KR102174578B1/ko active Active
- 2013-11-26 JP JP2015544190A patent/JP6309019B2/ja active Active
- 2013-11-26 NZ NZ709167A patent/NZ709167A/en unknown
- 2013-11-26 US US14/647,284 patent/US10260103B2/en active Active
- 2013-11-26 MX MX2015006680A patent/MX367366B/es active IP Right Grant
- 2013-11-26 BR BR112015012239-6A patent/BR112015012239B1/pt active IP Right Grant
- 2013-11-26 CA CA2892822A patent/CA2892822C/en active Active
- 2013-11-26 EP EP13812260.1A patent/EP2925886B1/en active Active
- 2013-11-26 WO PCT/US2013/071970 patent/WO2014085434A1/en not_active Ceased
- 2013-11-26 AU AU2013352339A patent/AU2013352339B2/en active Active
-
2015
- 2015-06-26 ZA ZA2015/04663A patent/ZA201504663B/en unknown
-
2019
- 2019-02-15 US US16/277,950 patent/US20190241969A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230366034A1 (en) | Compositions and methods for diagnosing lung cancers using gene expression profiles | |
| JP6309019B2 (ja) | 甲状腺腫瘍を診断するための組成物および方法 | |
| JP6592468B2 (ja) | 抗ｅｒｂｂ３抗体に対する腫瘍応答の推定 | |
| JP6285009B2 (ja) | 前立腺ガンの予後の検知及び判定のための組成物及び該検知及び判定方法 | |
| CN104093859A (zh) | 多基因生物标志物的鉴定 | |
| JP7392085B2 (ja) | 抗ｅｒｂｂ３抗体治療に対する食道癌の応答を予測する方法およびキット | |
| KR101943177B1 (ko) | 암 치료 | |
| EP2785873A2 (en) | Methods of treating breast cancer with taxane therapy | |
| KR20230025895A (ko) | 순환 종양 핵산 분자의 다중모드 분석 | |
| KR20170072685A (ko) | 삼중음성유방암의 아형 분류 방법 | |
| CN110573629B (zh) | 用于诊断早期胰腺癌的方法和试剂盒 | |
| CN114032308A (zh) | Fam83a、kpna2、krt6a和ldha联合作为肺腺癌生物标志物的用途 | |
| WO2014089055A1 (en) | Tivozanib response prediction | |
| US20210079479A1 (en) | Compostions and methods for diagnosing lung cancers using gene expression profiles | |
| JP6949315B2 (ja) | 肺扁平上皮癌と肺腺癌の鑑別評価方法 | |
| US20190010558A1 (en) | Method for determining the risk of recurrence of an estrogen receptor-positive and her2-negative primary mammary carcinoma under an endocrine therapy | |
| US11459605B2 (en) | Method for the diagnosis or prognosis, in vitro, of prostate cancer | |
| WO2023004460A1 (en) | Methods of detecting and/or diagnosing pancreatic cancer | |
| CN119570928A (zh) | 用于结直肠癌诊断和预后预测的lncRNA组合 | |
| CN120866519A (zh) | 用于肺癌免疫治疗适用性的检测系统及方法 | |
| JPWO2015115545A1 (ja) | 乳がんの転移又は再発リスクの評価方法 |